Anorexia/ Cachexia Clinical Trials & Research at Providence Medical Group

Providence Medical Group is currently enrolling patients for the following Anorexia/ Cachexia clinical trials:

Study to Assess the Effect of PF-06946860 on Appetite Following Subcutaneous Administration to Patients with Anorexia and Advanced Cancer(Pfizer C3651010​)

Treatment agent: PF-06946860
PI: Sara Keck, MD
Study Coordinator: Melissa Phillips // (707) 521-3833 ext. 1313
Resources and Links:
Sponsor: Pfizer